Physician profile
Glady Jacob
NPI 1831311588
$3,159.71
in general payments reported to CMS, 2019-2025
45 companies · $1,015 in 2025
The $1,015 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.11 · 2020: $101 · 2021: $36.15 · 2022: $315 · 2023: $915 · 2024: $752 · 2025: $1,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,469 · Travel and Lodging: $201 · Education: $12.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,468.51 |
| Travel and Lodging | $201.11 |
| Education | $12.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $505.99 | 2021-2025 | |
| Sk Life Science, INC. | $462.59 | 2022-2025 | Xcopri |
| Abbott Laboratories | $225.39 | 2025 | Infinity |
| Neurocrine Biosciences, INC. | $224.31 | 2023-2025 | Ingrezza, Ongentys |
| Teva Pharmaceuticals USA, INC. | $202.01 | 2023-2025 | Austedo Xr, Austedo Xr |
| Amneal Pharmaceuticals LLC | $142.34 | 2020-2025 | Crexont, Rytary |
| Neurelis, INC. | $140.76 | 2024 | Valtoco |
| Pfizer INC. | $93.57 | 2023-2025 | |
| Acorda Therapeutics, INC | $84.32 | 2023 | Inbrija, Ampyra |
| Lilly USA, LLC | $82.21 | 2022-2025 | Kisunla |
| Medtronic, INC. | $65.87 | 2025 | Percept PC Brainsense |
| Lundbeck LLC | $62.67 | 2023-2024 | Vyepti |
| Takeda Pharmaceuticals U.S.A., INC. | $60.86 | 2023-2024 | Glassia |
| Philips North America LLC | $48.37 | 2022 | |
| Sumitomo Pharma America, INC. | $46.75 | 2023 | Aptiom |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glady Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.